Indanorex
Chemical compound
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C12H17NO |
Molar mass | 191.274 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Indanorex (Dietor) is a stimulant drug which was developed in the 1970s.[1][2] It has appetite suppressant effects[medical citation needed] and also has antihypoglycemia effects.[3]
A chemical synthesis has been reported.[4]
See also
[edit]References
[edit]- ^ Jacques Georges Maillard, U.S. patent 3,885,045 (1975 to Logeais Labor Jacques).
- ^ FR 2322851 (1977 to Logeais Labor Jacques).
- ^ Giugliano D, Luyckx A, Binder D, Lefebvre P (February 1979). "Comparative effects of metformin and indanorex in the treatment of reactive hypoglycemia". International Journal of Clinical Pharmacology and Biopharmacy. 17 (2): 76–81. PMID 422305.
- ^ Maillard, J. et al, Bull. Soc. Chim. Fr., 1967, 2110.
DRAsTooltip Dopamine releasing agents |
| ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NRAsTooltip Norepinephrine releasing agents |
| ||||||||||||||
SRAsTooltip Serotonin releasing agents |
| ||||||||||||||
Others |
| ||||||||||||||
This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it. |